Clinical Trial to Evaluate the Safety and Efficacy of JTM201 to Treat Moderate or Severe Glabellar Lines
Clinical trial NCT06246552 · COMPLETED
Trial details
- NCT number
- NCT06246552
- Sponsor
- Jetema USA Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-26
- Primary completion
- 2025-06-05
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.